 "covid, coronavirus, vaccine, drug, pharma")
In order to prevent black-marketing and overpricing of Covid-19 drugs such as Remdesivir, India's drugs regulator DCGI has asked manufacturers to set up a helpline for patients and also put on their websites details of distributors and supply chain.
Rajesh Bhushan, the Officer on Special Duty, Union Health Ministry, told an online media briefing Thursday that it has been noticed that certain drugs are not available freely in the market.
Therefore, the Drugs Controller General of India (DCGI) has written letters to companies manufacturing them with two specific suggestions, he said.
"First suggestion was that these companies must put in place a 24x7
